TY - JOUR
T1 - A highly selective biosynthetic pathway to non-natural C 50 carotenoids assembled from moderately selective enzymes
AU - Furubayashi, Maiko
AU - Ikezumi, Mayu
AU - Takaichi, Shinichi
AU - Maoka, Takashi
AU - Hemmi, Hisashi
AU - Ogawa, Takuya
AU - Saito, Kyoichi
AU - Tobias, Alexander V.
AU - Umeno, Daisuke
N1 - Funding Information:
D.U. thanks F.H. Arnold, C. Schmidt-Dannert and A. Hartwick for initiating the progenitor project of this work. We thank N. Tokuriki, F.H. Arnold, Y. Yokobayashi, S. Atsumi, R.S. Cox III and N. Misawa for discussions and critical reading of the manuscript. D.U. is supported by the JST PRESTO, the JSPS KAKENHI Grant Numbers 18686066 and 23108507, and the Nanohana Foundation. M.F. is supported by a JSPS fellowship for young scientists. This work is financially supported by the Mishima-Kaiun Memorial Foundation, the Futaba Electronics Memorial Foundation and the Shorai Foundation for Science and Technology.
Publisher Copyright:
© 2015 Macmillan Publishers Limited.
PY - 2015/7/14
Y1 - 2015/7/14
N2 - Synthetic biology aspires to construct natural and non-natural pathways to useful compounds. However, pathways that rely on multiple promiscuous enzymes may branch, which might preclude selective production of the target compound. Here, we describe the assembly of a six-enzyme pathway in Escherichia coli for the synthesis of C 50-astaxanthin, a non-natural purple carotenoid. We show that by judicious matching of engineered size-selectivity variants of the first two enzymes in the pathway, farnesyl diphosphate synthase (FDS) and carotenoid synthase (CrtM), branching and the production of non-target compounds can be suppressed, enriching the proportion of C 50 backbones produced. We then further extend the C 50 pathway using evolved or wild-type downstream enzymes. Despite not containing any substrate-or product-specific enzymes, the resulting pathway detectably produces only C 50 carotenoids, including ∼90% C50-astaxanthin. Using this approach, highly selective pathways can be engineered without developing absolutely specific enzymes.
AB - Synthetic biology aspires to construct natural and non-natural pathways to useful compounds. However, pathways that rely on multiple promiscuous enzymes may branch, which might preclude selective production of the target compound. Here, we describe the assembly of a six-enzyme pathway in Escherichia coli for the synthesis of C 50-astaxanthin, a non-natural purple carotenoid. We show that by judicious matching of engineered size-selectivity variants of the first two enzymes in the pathway, farnesyl diphosphate synthase (FDS) and carotenoid synthase (CrtM), branching and the production of non-target compounds can be suppressed, enriching the proportion of C 50 backbones produced. We then further extend the C 50 pathway using evolved or wild-type downstream enzymes. Despite not containing any substrate-or product-specific enzymes, the resulting pathway detectably produces only C 50 carotenoids, including ∼90% C50-astaxanthin. Using this approach, highly selective pathways can be engineered without developing absolutely specific enzymes.
UR - http://www.scopus.com/inward/record.url?scp=84937045641&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937045641&partnerID=8YFLogxK
U2 - 10.1038/ncomms8534
DO - 10.1038/ncomms8534
M3 - Article
C2 - 26168783
AN - SCOPUS:84937045641
SN - 2041-1723
VL - 6
JO - Nature communications
JF - Nature communications
M1 - 7534
ER -